Ocular Therapeutix, Inc

Ownership Transactions Reported by 22 Insiders

Symbol
OCUL on Nasdaq
Location
15 Crosby Drive, Bedford, MA

Insiders trading volume in the past year

Ocular Therapeutix, Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Summer Road Llc 10%+ Owner $64.6M Feb 26, 2024
Pravin Dugel Executive Chairman, President and CEO, Director $42M -$745K -1.74% Sep 9, 2025
Donald Notman Chief Financial Officer and Chief Operating Officer. Exhibit Index Exhibit 24 - Power of Attorney $3.84M -$149K -3.75% Sep 2, 2025
Sanjay Nayak Chief Strategy Officer $3.37M -$65.3K -1.9% Aug 25, 2025
Nadia Waheed Chief Medical Officer $3.12M -$112K -3.45% Aug 12, 2025
Antony C. Mattessich President and CEO, Director $2.89M Feb 3, 2024
Jeffrey S. Heier Chief Scientific Officer $2.75M -$222K -7.46% Oct 2, 2025
Peter Kaiser Chief Development Officer $2.14M -$211K -8.95% Oct 2, 2025
Namrata Saroj Chief Business Officer $1.87M -$278K -12.9% Nov 5, 2025
Richard L. Lindstrom Md Director $1.39M +$69.6K +5.27% Jun 11, 2025
Michael H. Goldstein President, Ophthalmology & CMO $1.19M Feb 3, 2022
Steve Lawrence Meyers Chief Commercial Officer $1.14M Jun 11, 2025
Todd Anderman Chief Legal Officer $1.08M -$137K -11.3% Oct 8, 2025
Philip C. Strassburger General Counsel $785K Feb 3, 2024
Rabia Gurses Ozden Chief Medical Officer $744K Feb 3, 2024
Charles M. Warden Director $644K Jun 11, 2025
Christopher G. White Chief Business Officer $601K Feb 3, 2024
Leslie J. Williams Director $383K Jun 11, 2025
Adrienne L. Graves Director $373K Jun 11, 2025
Raines Merilee Director $350K Jun 11, 2025
Seung Suh Hong Director $350K Jun 11, 2025
Bruce Peacock Director Jun 18, 2021

Recent Insider Transactions by Companies or Individuals for Ocular Therapeutix, Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.